SNPX
Income statement / Annual
Last year (2024), Synaptogenix, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Synaptogenix, Inc.'s net income was -$12.77 M.
See Synaptogenix, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$5.58 K
|
$6.35 K
|
$5.71 K
|
$4.97 K
|
$4.87 K
|
$4.39 K
|
$3.00 K
|
Gross Profit |
$0.00
|
-$6.35 K
|
-$5.71 K
|
-$4.97 K
|
-$4.87 K
|
-$4.39 K
|
-$3.00 K
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$1.60 M
|
$1.97 M
|
$6.32 M
|
$4.34 M
|
$3.07 M
|
$5.67 M
|
$4.89 M
|
General & Administrative Expenses |
$5.21 T
|
$6.34 M
|
$9.81 M
|
$8.28 M
|
$8.09 M
|
$9.84 M
|
$0.00
|
Selling & Marketing Expenses |
-$5.21 T
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$5.21 M
|
$6.34 M
|
$9.81 M
|
$8.28 M
|
$8.09 M
|
$9.84 M
|
$6.26 M
|
Other Expenses |
$0.00
|
-$0.00
|
$0.00
|
$0.00
|
$28.36 K
|
$0.00
|
$0.00
|
Operating Expenses |
$6.81 M
|
$8.31 M
|
$16.13 M
|
$12.62 M
|
$11.16 M
|
$15.51 M
|
$11.15 M
|
Cost And Expenses |
$0.00
|
$8.31 M
|
$16.13 M
|
$12.62 M
|
$11.16 M
|
$15.51 M
|
$11.15 M
|
Interest Income |
$1.28 M
|
$1.65 M
|
$335.04 K
|
$7.11 K
|
$153.21 K
|
$378.71 K
|
$127.11 K
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$5.58 K
|
$6.35 K
|
$5.71 K
|
$4.97 K
|
$4.87 K
|
$4.39 K
|
$3.00 K
|
EBITDA |
-$12.76 M |
-$8.31 M |
-$16.13 M |
-$12.61 M |
-$11.15 M |
-$15.51 M |
-$11.02 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
-$5.96 M
|
$2.28 M
|
$10.56 M
|
$7.11 K
|
-$1.55 M
|
$378.71 K
|
$127.11 K
|
Income Before Tax |
-$12.77 M
|
-$6.04 M
|
-$5.57 M
|
-$12.61 M
|
-$12.70 M
|
-$15.13 M
|
-$11.02 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
-$789.91 B
|
$0.00
|
-$115.89 K
|
-$7.11 K
|
$1.55 M
|
-$378.71 K
|
$0.00
|
Net Income |
-$12.77 M
|
-$6.04 M
|
-$5.46 M
|
-$12.60 M
|
-$14.25 M
|
-$14.76 M
|
-$11.02 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
EPS |
10990077 |
-29.56 |
-20.35 |
-62.87 |
-300.78 |
-300.87 |
-46.33 |
EPS Diluted |
10990077 |
-29.56 |
-20.35 |
-62.87 |
-300.78 |
-300.87 |
-46.33 |
Weighted Average Shares Out |
$1.23 M
|
$204.00 K
|
$273.00 K
|
$200.00 K
|
$42.00 K
|
$50.00 K
|
$237.91 K
|
Weighted Average Shares Out Diluted |
$1.23 M
|
$466.08 K
|
$279.57 K
|
$200.60 K
|
$50.30 K
|
$50.30 K
|
$237.91 K
|
Link |
|
|
|
|
|
|
|